Commure sells an AI platform to hospitals and health systems that automates clinical documentation (ambient scribe), revenue cycle management and other administrative workflows.
Commure sells software to hospitals, health systems and physician practices. Its products include ambient AI clinical documentation, autonomous coding and revenue cycle automation, AI agents for physician workflows, and staff safety and care coordination tools. They integrate with EHRs such as MEDITECH and Epic. It was incubated by General Catalyst in 2017 and began as a healthcare developer platform. On May 19, 2026 it announced $70M in financing at a $7B post-money valuation, led by General Catalyst with Sequoia Capital and Morgan Stanley. Total funding is about $823M, including a $200M growth financing in June 2025. Third-party estimates put ARR above $200M as of mid-2025. Headcount estimates range from about 700 to 1,600.
General Catalyst's healthcare AI platform (merged with Athelas): ambient scribe, revenue-cycle automation and patient engagement. ARR was $105M in March 2024, growing 150%. Valuation: $7B post-money, $70M Series D (May 2026, General Catalyst).
BoardGeneral CatalystVenture capital· Hemant Taneja (CEO and Managing Partner at General Catalyst; Co-founder and Executive Chair of Commure)71 partners on file
BoardGeneral CatalystVenture capital· Quentin Clark (Managing Director at General Catalyst)71 partners on file
BoardHCA HealthcareVenture capital· Michael Schlosser (Senior Vice President and Chief Transformation Officer at HCA Healthcare (listed as Commure board member; HCA representation inferred))3 partners on file
